PAB Price sensitive 20 May 2026, 9:31 AM

Patrys advances RLS-2202 toward Phase 1 Clinical Trial

PATRYS Ltd

No summary is available for this announcement — open the PDF to read it in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in